Published in Osteoporos Int on September 08, 2011
Skeletal effects of zoledronic acid in an animal model of chronic kidney disease. Osteoporos Int (2012) 0.95
High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis. J Am Soc Nephrol (2015) 0.89
Challenges in implementing and maintaining osteoporosis therapy. Int J Womens Health (2014) 0.86
Role of TGF-β in a mouse model of high turnover renal osteodystrophy. J Bone Miner Res (2014) 0.85
Changes in skeletal collagen cross-links and matrix hydration in high- and low-turnover chronic kidney disease. Osteoporos Int (2014) 0.84
Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol (2015) 0.83
Uremic osteoporosis. Kidney Int Suppl (2011) (2013) 0.83
Chronic kidney disease and osteoporosis: evaluation and management. Bonekey Rep (2014) 0.81
Circulating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health Study. J Bone Miner Res (2014) 0.80
Chronic kidney disease and the skeleton. Bone Res (2014) 0.79
Relationship between bone mineral density and moderate to severe chronic kidney disease among general population in Korea. J Korean Med Sci (2013) 0.77
Chronic kidney disease and bone metabolism. J Bone Miner Metab (2015) 0.77
Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database. BMC Musculoskelet Disord (2016) 0.75
Evaluation of Exercise Tolerance in Dialysis Patients Performing Tai Chi Training: Preliminary Study. Evid Based Complement Alternat Med (2016) 0.75
Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities. Osteoporos Int (2017) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2009) 12.66
Absence of evidence is not evidence of absence. BMJ (1995) 10.36
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int (2006) 7.02
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2006) 5.69
Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res (2004) 3.37
FRAX and its applications to clinical practice. Bone (2009) 3.32
Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int (2000) 3.29
Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27
Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement (2001) 2.72
Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis (2000) 2.19
Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol (2006) 1.92
Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol (2006) 1.91
Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res (2007) 1.88
PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis (2006) 1.86
Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int (2007) 1.70
Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system. J Bone Miner Res (2011) 1.68
Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res (2006) 1.63
Is the paradigm shifting? Bone (2003) 1.47
Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int (2000) 1.44
Analyzing cortical bone cross-sectional geometry by peripheral QCT: comparison with bone histomorphometry. J Clin Densitom (2007) 1.43
Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol (1999) 1.43
Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res (2005) 1.42
Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int (1999) 1.40
Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis (1999) 1.38
Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res (2007) 1.31
Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int (2006) 1.29
Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis (2007) 1.27
Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol (2010) 1.26
Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Osteoporos Int (2008) 1.20
Accuracy of pQCT for evaluating the aged human radius: an ashing, histomorphometry and failure load investigation. Osteoporos Int (2006) 1.20
Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab (1999) 1.16
A structural approach to renal bone disease. J Bone Miner Res (1998) 1.15
Role of Klotho in aging, phosphate metabolism, and CKD. Am J Kidney Dis (2011) 1.15
Osteoporosis in end-state renal disease. Semin Nephrol (1999) 1.14
Quantitative high-resolution magnetic resonance imaging reveals structural implications of renal osteodystrophy on trabecular and cortical bone. J Magn Reson Imaging (2004) 1.11
Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease. Osteoporos Int (2009) 1.08
Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens (2003) 1.08
Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis (2002) 1.07
Retracted Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. Am J Kidney Dis (2009) 1.05
Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab (1999) 1.03
Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients. J Bone Miner Metab (2006) 1.03
Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.03
A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min. Osteoporos Int (2004) 1.00
Femoral neck fractures in patients receiving long-term dialysis. Clin Orthop Relat Res (1990) 1.00
Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. Kidney Int (2002) 0.99
25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J Bone Miner Res (2006) 0.98
Rising from a chair: a simple screening test for physical function in predialysis patients. Scand J Urol Nephrol (2008) 0.94
An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment. J Clin Endocrinol Metab (2006) 0.93
The relationship between physical performance measures, bone mineral density, falls, and the risk of peripheral fracture: a cross-sectional analysis. BMC Public Health (2009) 0.92
Impaired muscle strength is associated with fractures in hemodialysis patients. Osteoporos Int (2006) 0.90
The past, present, and future of bone morphometry: its contribution to an improved understanding of bone biology. J Bone Miner Metab (2005) 0.90
Falls are associated with decreased renal function and insufficient calcitriol production by the kidney. J Steroid Biochem Mol Biol (2006) 0.89
Postural balance and self-reported balance confidence in older adults with a hip fracture history. Gerontology (2009) 0.89
Low grip strength is associated with bone mineral density and vertebral fracture in women. Rheumatology (Oxford) (2005) 0.89
Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5. Clin Nephrol (2008) 0.88
Fracture and bone mineral density in hemodialysis patients. Clin Nephrol (2000) 0.88
Primary hyperparathyroidism: iliac crest cortical thickness, structure, and remodeling evaluated by histomorphometric methods. Bone (1994) 0.87
Diagnosis and treatment of osteoporosis in chronic renal disease. Semin Nephrol (2009) 0.87
Clinical Significance of FGF-23 in Patients with CKD. Int J Nephrol (2011) 0.86
Risk factors for hip fracture in hemodialysis patients. Am J Nephrol (2002) 0.86
Evaluation of cortical bone by peripheral quantitative computed tomography in continuous ambulatory peritoneal dialysis patients. Hemodial Int (2006) 0.85
Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D. J Bone Miner Metab (2007) 0.84
Use of bone turnover markers in the real world: are we there yet? J Bone Miner Res (2009) 0.83
Estimation of bone mineral density and architectural parameters of the distal radius in hemodialysis patients using peripheral quantitative computed tomography. J Biomech (2004) 0.81
Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporos Int (1998) 0.81
Renal osteodystrophy. N Engl J Med (1989) 0.80
Update on renal osteodystrophy: pathogenesis and clinical management. Am J Med Sci (1999) 0.80
Fragility fractures in chronic kidney disease: an opinion-based approach. Cleve Clin J Med (2009) 0.80
Independent from muscle power and balance performance, a creatinine clearance below 65 ml/min is a significant and independent risk factor for falls and fall-related fractures in elderly men and women diagnosed with osteoporosis. Osteoporos Int (2009) 0.80
Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation. Clin Transplant (2008) 0.80
Dialysis osteodystrophy. A study involving 94 patients. Medicine (Baltimore) (1985) 0.79
The relationship between circulating fibroblast growth factor 23 and bone metabolism factors in Korean hemodialysis patients. Clin Exp Nephrol (2010) 0.78
Non-invasive measurements of bone strength: promise and peril. J Musculoskelet Neuronal Interact (2004) 0.78
Cardiovascular mortality and morbidity in dialysis patients. Miner Electrolyte Metab (1999) 0.78
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA (2001) 6.66
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med (1990) 4.10
A classification of marginal tissue recession. Int J Periodontics Restorative Dent (1985) 3.62
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med (1993) 3.23
The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2006) 2.24
Eosinophilic prostatitis and prostatic specific antigen. Br J Urol (1992) 2.04
Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA (1999) 1.99
Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer (1995) 1.98
Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med (1987) 1.93
Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women. Osteoporos Int (1993) 1.84
The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med (1987) 1.79
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. Osteoporos Int (2008) 1.76
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis (2005) 1.66
Sexual activity, contraceptive use, and other risk factors for symptomatic and asymptomatic bacteriuria. A case-control study. Ann Intern Med (1987) 1.60
Management of prolonged pregnancy: induction of labor versus antepartum fetal testing. Am J Obstet Gynecol (1987) 1.56
Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab (2000) 1.51
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet. Osteoporos Int (2011) 1.45
Bisphosphonates: safety and efficacy in the treatment and prevention of osteoporosis. Am Fam Physician (2000) 1.43
Coronal positioning of existing gingiva: short term results in the treatment of shallow marginal tissue recession. J Periodontol (1989) 1.42
Tolerability of risedronate in postmenopausal women intolerant of alendronate. Aging (Milano) (2001) 1.40
Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study. Br J Dermatol (2012) 1.39
"Evidence-based" or "logic-based" medicine? Osteoporos Int (2010) 1.38
The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med (1987) 1.38
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial. Osteoporos Int (2012) 1.29
Root coverage using a free soft tissue autograft following citric acid application. Part 1: Technique. Int J Periodontics Restorative Dent (1982) 1.28
Posttraumatic stress two years after the Oklahoma City bombing in youths geographically distant from the explosion. Psychiatry (2000) 1.24
Root coverage using the free soft tissue autograft following citric acid application. III. A successful and predictable procedure in areas of deep-wide recession. Int J Periodontics Restorative Dent (1985) 1.17
Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group. Osteoporos Int (1999) 1.15
Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2008) 1.15
High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures. Hum Reprod (2009) 1.12
Renal cell carcinoma: unusual systemic manifestations. Medicine (Baltimore) (1976) 1.11
Effects of the Scopes trial. Was it a victory for evolutionists? Science (1974) 1.09
Treatment of alcoholic acidosis: the role of dextrose and phosphorus. Arch Intern Med (1978) 1.08
Bone mineral density in elite junior Olympic weightlifters. Med Sci Sports Exerc (1993) 1.07
The virtual standardized patient. Simulated patient-practitioner dialog for patient interview training. Stud Health Technol Inform (2000) 1.06
Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2007) 1.05
Acute metabolic alkalosis perpetuating hypercarbia. A role for acetazolamide in chronic obstructive pulmonary disease. JAMA (1977) 1.05
Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer? Int J Cancer (1990) 1.05
Hypodipsia in geriatric patients. Am J Med (1982) 1.04
The frenectomy combined with a laterally positioned pedicle graft. Functional and esthetic considerations. J Periodontol (1985) 1.04
Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis. Osteoporos Int (2014) 1.03
Pathogenic mechanisms in early norepinephrine-induced acute renal failure: functional and histological correlates of protection. Kidney Int (1978) 1.03
Hypothermia attenuates the normal increase in interleukin 1 beta RNA and nerve growth factor following traumatic brain injury in the rat. J Neurotrauma (1995) 1.03
Upregulation of nerve growth factor following cortical trauma. Exp Neurol (1994) 1.02
Traumatic grief in a convenience sample of victims seeking support services after a terrorist incident. Ann Clin Psychiatry (2001) 1.01
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study. J Bone Miner Res (1998) 1.00
Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. Osteoporos Int (2008) 0.99
Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. Cancer Res (1997) 0.99
Oral contraceptives and other risk factors for gallbladder disease. Clin Pharmacol Ther (1986) 0.98
Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease. Osteoporos Int (2012) 0.98
An approach for identifying postmenopausal women age 50-64 years at increased short-term risk for osteoporotic fracture. Osteoporos Int (2007) 0.96
Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients. JAMA (1980) 0.93
Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks. J Womens Health Gend Based Med (1999) 0.92
Airway hyperresponsiveness in guinea pigs exposed to acid-coated ultrafine particles. J Toxicol Environ Health (1992) 0.92
Traumatic renal artery thrombosis. Am J Med (1986) 0.92
Improved precision with Hologic Apex software. Osteoporos Int (2008) 0.91
Effects of furosemide and acetylcholine in norepinephrine-induced acute renal failure. Am J Physiol (1978) 0.91
Clinical performance of a highly portable, scanning calcaneal ultrasonometer. Osteoporos Int (2001) 0.90
Root coverage grafting for regeneration and aesthetics. Periodontol 2000 (1993) 0.90
Diagnosis and management of osteoporosis: guidelines for the utilization of bone densitometry. Calcif Tissue Int (1997) 0.89
The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal antiinflammatory drugs. Arthritis Rheum (1987) 0.88
The epidemiology of the acute flank pain syndrome from suprofen. Clin Pharmacol Ther (1989) 0.88
Intrinsic GUS-like activities in seed plants. Plant Cell Rep (1990) 0.87
Retroviral-like sequences specifically expressed in the rat ovary detect genetic differences between normal and transformed rat ovarian surface epithelial cells. Endocrinology (1995) 0.87
The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease. Osteoporos Int (2013) 0.87
PINP as a biological response marker during teriparatide treatment for osteoporosis. Osteoporos Int (2014) 0.87
Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus. Arthritis Rheum (1993) 0.86
Sulfuric acid-layered ultrafine particles potentiate ozone-induced airway injury. J Toxicol Environ Health (1991) 0.85
Balloon dilatation of the prostate--should it have a place in the urologist's armamentarium? J R Soc Med (1993) 0.84
Effect of ozone exposure on lung functions and plasma prostaglandin and thromboxane concentrations in guinea pigs. Toxicol Appl Pharmacol (1987) 0.84
Comparative effect of diuretics on renal water excretion in hyponatraemic oedematous disorders. Clin Sci (Lond) (1982) 0.83
Rib fracture as a predictor of future fractures in young and older postmenopausal women: National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2011) 0.83
Teaching ethics in psychiatry: a one-day workshop for clinical students. J Med Ethics (1995) 0.82
Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study. Osteoporos Int (2007) 0.82
Hormonal control of renal water excretion. Kidney Int (1976) 0.81
Polyuric prerenal failure. Arch Intern Med (1980) 0.81
Standards and guidelines for performing central dual X-ray densitometry from the Canadian Panel of International Society for Clinical Densitometry. J Clin Densitom (2002) 0.81
Controversies in bone mineral density diagnostic classifications. Calcif Tissue Int (2000) 0.81
Surgical excision of first cleft branchial fistulae. Br J Surg (1984) 0.81
Biochemical epidemiology of gallbladder cancer. Hepatology (1996) 0.80
Hyperbaric oxygen causes fetal wastage in rats. Lancet (1969) 0.80
Hypotensive sequelae of diazoxide and hydralazine therapy. JAMA (1977) 0.80
Alternate strategies in lesion-induced reactive synaptogenesis: differential expression of L1 in two populations of sprouting axons. Exp Neurol (1995) 0.80
Pharmacotherapy for alcohol dependence. Evid Rep Technol Assess (Summ) (1999) 0.80
Fracture incidence in a large cohort of men age 30 years and older with osteoporosis. Osteoporos Int (2015) 0.80
Standards and guidelines for performing central dual X-ray densitometry from the Canadian panel of International Society for Clinical Densitometry. J Clin Densitom (2002) 0.80
In vitro characterization of hybrid promoters and altered tryptophan operon promoters. Biochemistry (1985) 0.80
Pathophysiology of tumor progression in human gallbladder: flow cytometry, CEA, and CA 19-9 levels in bile and serum in different stages of gallbladder disease. J Natl Cancer Inst (1989) 0.78
Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys. N Engl J Med (1978) 0.78
Exploiting discreteness for switching in waveguide arrays. Opt Lett (1996) 0.78
Effect of ozone and histamine on airway permeability to horseradish peroxidase in guinea pigs. J Toxicol Environ Health (1986) 0.78
The effect of potassium loading on sodium excretion and plasma renin activity in Addisonian man. J Clin Invest (1975) 0.78
Effect of hyperbaric oxygen on cardiogenesis in the rat. Biol Neonate (1971) 0.78
Increasing the amount of attached gingiva using a modified apically repositioned flap. J Periodontol (1999) 0.77
Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. Clin Chem (1994) 0.77
A novel transurethral microwave thermal ablation system to treat benign prostatic hyperplasia: results of a prospective multicenter clinical trial. J Urol (1997) 0.77
Genome scanning detects amplification of the cathepsin B gene (CtsB) in transformed rat ovarian surface epithelial cells. J Soc Gynecol Investig (1999) 0.77